NBCF’s vision is to fund research that will contribute to achieving the organisation’s aspirational goal of zero deaths from breast cancer by 2030.
Applicants seeking funding are advised to consider the following research priorities in their applications.
- New/optimized treatments for triple negative breast cancer, comprising new target discovery, new delivery methods, new drugs, new therapeutic regimes etc
- New/optimized treatments for metastatic/locally advanced breast cancer comprising new target discovery, new delivery methods, new drugs, new therapeutic regimes etc
- Health services delivery, comprising big data linkage, epidemiological research to address disparities and variances in outcomes, translation of evidence into policy and practice, quality of healthcare etc